LUXEMBOURG INST OF HEALTH LIH has a total of 15 patent applications. It increased the IP activity by 250.0%. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ANDEL INST VAN, GENQUEST INC and LEAP THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | United States | 3 | |
#4 | Luxembourg | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Measuring microorganism processes | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Devaux Yvan | 6 |
#2 | Ollert Markus | 6 |
#3 | Zhang Lu | 6 |
#4 | Leonard Catherine | 4 |
#5 | Bredehorst Reinhard | 4 |
#6 | Grunwald Thomas | 4 |
#7 | Vausort Melanie | 2 |
#8 | Chevigné Andy | 2 |
#9 | Dervillez Xavier | 2 |
#10 | Devaux Carole | 2 |
Publication | Filing date | Title |
---|---|---|
WO2021069543A1 | Inhibitor of dj-1 for use in treating immunoaging | |
WO2021009251A1 | Specific ackr2 modulators for use in therapy | |
WO2020225070A1 | Novel selective ackr3 modulators and uses thereof | |
WO2019076478A1 | Hydrogel-embedded oligodeoxynucleotides as tolerogenic adjuvant for subcutaneous immunotherapy | |
EP3787670A1 | Induction of allergen-specific tregs prior to oral or sublingual immunotherapy of food allergy | |
EP3630999A1 | Novel circular rna biomarkers for heart failure | |
US2019382458A1 | Multifunctional Heteromultimeric Constructs | |
LU92830B1 | Biomarkers for heart failure |